211 related articles for article (PubMed ID: 36081939)
1. Corporate social responsibility of pharmaceutical industry in Korea.
Bae G; Ahn JH; Lim KM; Bae S
Front Pharmacol; 2022; 13():950669. PubMed ID: 36081939
[No Abstract] [Full Text] [Related]
2. Does CEO tenure moderate the link between corporate social responsibility and business performance in small- and medium-sized enterprises?
Lee SM; Sinha PN; Bae JE; Lee YK
Front Psychol; 2022; 13():1037245. PubMed ID: 36562052
[TBL] [Abstract][Full Text] [Related]
3. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
Droppert H; Bennett S
Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
[TBL] [Abstract][Full Text] [Related]
4. Mapping stakeholders' relationships management in fulfilling corporate social responsibility: A study of China's construction industry.
Zhang Y; Jiang W; Ye K; Liang Y; Wang X
PLoS One; 2024; 19(1):e0294588. PubMed ID: 38180962
[TBL] [Abstract][Full Text] [Related]
5. Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea.
Lee H; Kim SY; Kim G; Kang HY
PLoS One; 2019; 14(8):e0221321. PubMed ID: 31430330
[TBL] [Abstract][Full Text] [Related]
6. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
Kato M; Ishikawa H; Okuhara T; Kiuchi T
Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
[TBL] [Abstract][Full Text] [Related]
7. Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US.
Wakefield T; Glantz SA; Apollonio DE
JAMA Netw Open; 2022 Aug; 5(8):e2228088. PubMed ID: 35997980
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting the Implementation of Corporate Social Responsibility in the Health Technology Industry in Greece.
Liopa M; Geitona M; Latsou D
Cureus; 2023 Jun; 15(6):e39946. PubMed ID: 37409209
[TBL] [Abstract][Full Text] [Related]
9. The Role of Corporate Social Responsibility and Corporate Image in Times of Crisis: The Mediating Role of Customer Trust.
Chen CC; Khan A; Hongsuchon T; Ruangkanjanases A; Chen YT; Sivarak O; Chen SC
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444023
[TBL] [Abstract][Full Text] [Related]
10. Comparation of differences in the performance of corporate social responsibility between Chinese and American pharmaceutical enterprises-based on corporate social responsibility report.
Xu H; Zhang M; Chu S
Front Pharmacol; 2023; 14():1116466. PubMed ID: 37284320
[No Abstract] [Full Text] [Related]
11. Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.
Dănescu T; Popa MA
Global Health; 2020 Dec; 16(1):117. PubMed ID: 33302949
[TBL] [Abstract][Full Text] [Related]
12. Interfaces of occupational health management and corporate social responsibility: a multi-centre qualitative study from Germany.
Kuhn E; Müller S; Teusch C; Tanner G; Schümann M; Baur C; Bamberg E; Heidbrink L; McLennan S; Buyx A
BMC Public Health; 2021 Jun; 21(1):1042. PubMed ID: 34078332
[TBL] [Abstract][Full Text] [Related]
13. The physical activity and nutrition-related corporate social responsibility initiatives of food and beverage companies in Canada and implications for public health.
Potvin Kent M; Pauzé E; Guo K; Kent A; Jean-Louis R
BMC Public Health; 2020 Jun; 20(1):890. PubMed ID: 32517669
[TBL] [Abstract][Full Text] [Related]
14. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
Zhang Y; Yang F
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
[TBL] [Abstract][Full Text] [Related]
15. Impact of China's Vaccine Incidents on the Operational Efficiency of Biopharmaceutical Companies.
Chai KC; Tao R; Chang KC; Yang Y
Front Public Health; 2020; 8():93. PubMed ID: 32322567
[No Abstract] [Full Text] [Related]
16. Occupational safety and health aspects of corporate social responsibility reporting in Japan from 2004 to 2012.
Nagata T; Nakata A; Mori K; Maruyama T; Kawashita F; Nagata M
BMC Public Health; 2017 May; 17(1):381. PubMed ID: 28464860
[TBL] [Abstract][Full Text] [Related]
17. Web-Based Communication of Socially Responsible Activities by Gambling Operators.
Tetrevova L; Patak M
J Gambl Stud; 2019 Dec; 35(4):1441-1455. PubMed ID: 30859389
[TBL] [Abstract][Full Text] [Related]
18. The illusion of righteousness: corporate social responsibility practices of the alcohol industry.
Yoon S; Lam TH
BMC Public Health; 2013 Jul; 13():630. PubMed ID: 23822724
[TBL] [Abstract][Full Text] [Related]
19. Value creation and CSR.
Donaldson T
J Bus Econ; 2023 Jan; ():1-21. PubMed ID: 38625357
[TBL] [Abstract][Full Text] [Related]
20. Occupational safety and health aspects of corporate social responsibility (CSR) in Japanese companies listed on the Tokyo Stock Exchange (TSE) first section.
Kawashita F; Taniyama Y; Hwi SY; Fujisaki T; Kameda T; Mori K
J Occup Health; 2005 Nov; 47(6):533-9. PubMed ID: 16369117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
